Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)

India · Delayed Price · Currency is INR

1,119.10

+40.85 (3.79%)

Last updated: Sep 7, 2026, 9:35 AM IST

Symbiotec Pharmalab Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	8,691	8,691	7,516	7,162	5,665	6,818
Revenue Growth	27.48%	15.65%	4.93%	26.43%	-16.91%	-
Gross Profit	5,248	5,248	4,324	3,759	2,588	3,296
Operating Income	1,871	1,871	1,611	1,339	441.96	1,072
Net Income	1,099	1,099	967.84	1,002	234.86	775.27
Earnings Per Share	19.00	19.00	17.36	18.00	4.30	14.18
EPS Growth	34.01%	9.45%	-3.54%	319.01%	-69.71%	-

Revenue by Geography

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	2,865	2,865	3,368	2,867	2,672	3,216
Europe	2,530	2,530	2,271	2,124	-	-
United States	1,140	1,140	302.02	642.6	-	-
Rest of World	2,157	2,157	1,575	1,528	-	-
Total	8,691	8,691	7,516	7,162	5,665	6,818

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	101.25	101.25	264.69	75.63	54.24	95.4
Total Debt	3,910	3,910	5,444	2,506	2,200	657.87
Net Cash (Debt)	-3,809	-3,809	-5,180	-2,430	-2,145	-562.47
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-65.86	-65.86	-92.89	-43.66	-39.23	-10.29

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	1,746	1,746	472.56	1,875	692.38	177.11
Capital Expenditures	-2,257	-2,257	-3,081	-2,098	-2,244	-723.5
Free Cash Flow	-511.26	-511.26	-2,609	-222.69	-1,552	-546.39
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	60.39%	60.39%	57.54%	52.49%	45.68%	48.34%
Operating Margin	21.53%	21.53%	21.43%	18.69%	7.80%	15.72%
Pretax Margin	17.65%	17.65%	19.56%	18.29%	6.75%	15.50%
Profit Margin	12.64%	12.64%	12.88%	13.99%	4.15%	11.37%
FCF Margin	-5.88%	-5.88%	-34.71%	-3.11%	-27.39%	-8.01%